Welcome to Planet Biotechnology, Inc. Clinical Stage Company Discovering, Developing and Commercializing New Antibody- based Therapeutic and Preventative Products Through Cultivation of Genetically Modi- fied Green Plants To Meet Significant Underserved Medical Needs. A portion of each heavy chain combines with a light chain to make the Fab. The binding sites of the antibody are located on the ends of each Fab.   more »     Our Product CaroRXTM Clinical Stage Company Discovering, Developing and Commercializing. RhinoRXTM A Portion of each heavy chain combines with a light chain to make the Fab. BotoRXTM Complete preclinical and clinical (Phase I trial University of Maryland).   Our Technology   Despite the many advantages of SIgA over other antibody classes, prior to 1995 it had not been possible to produce mono-specific SIgA in large quantity.
	© 2008 Planet Biotechnology, Inc. | Site Map